advertisement
11.8 Neuroprotection (17)
Showing records 1 to 17
Display all abstracts in classification 11.8 Neuroprotection
Search within classification 11.8 Neuroprotection19654 Targeting amyloid-β in glaucoma treatment
Guo L; Salt TE; Luong V; Wood N; Cheung W; Maass A; Ferrari G; Russo-Marie F; Sillito AM; Cheetham ME
Proceedings of the National Academy of Sciences of the United States of America 2007; 104: 13444-13449
19662 CaMKIIalphaB mediates a survival response in retinal ganglion cells subjected to a glutamate stimulus
Fan W; Cooper NG
Investigative Ophthalmology and Visual Science 2007; 48: 3854-3863
19249 The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma
Harada T; Harada C; Nakamura K; Quah H-MA; Okumura A; Namekata K; Saeki T; Aihara M; Yoshida H; Mitani A
Journal of Clinical Investigation 2007; 117: 1763-1770
19484 Regulation of cell death and survival pathways in experimental glaucoma
Levkovitch-Verbin H; Harizman N; Dardik R; Nisgav Y; Vander S; Melamed S
Experimental Eye Research 2007; 85: 250-258
19295 Survival and axonal regeneration of off-center retinal ganglion cells of adult cats are promoted with an anti-glaucoma drug, nipradilol, but not BDNF and CNTF
Yata T; Nakamura M; Sagawa H; Tokita Y; Terasaki H; Watanabe M
Neuroscience 2007; 148: 53-64
19483 Regeneration of retinal ganglion cell axons in organ culture is increased in rats with hereditary buphthalmos
Lasseck J; Schröer U; Koenig S; Thanos S
Experimental Eye Research 2007; 85: 90-104
19437 Neuroprotective effect of topically applied brimonidine tartrate 0.2% in endothelin-1-induced optic nerve ischaemia model
Aktaş Z; Gürelik G; Akyürek N; Onol M; Hasanreisoğlu B
Clinical and Experimental Ophthalmology 2007; 35: 527-34
19637 Optic nerve restoration: New perspectives
Bull ND; Martin KR
Journal of Glaucoma 2007; 16: 506-511
19608 Chemotactic effect of ciliary neurotrophic factor on macrophages in retinal ganglion cell survival and axonal regeneration
Cen LP; Luo JM; Zhang CW; Fan YM; Song Y; So KF; van Rooijen N; Pang CP; Lam DS; Cui Q
Investigative Ophthalmology and Visual Science 2007; 48: 4257-4266
19476 Clinical evaluation of the neuroprotective effect of alpha-tocopherol against glaucomatous damage
Engin KN; Engin G; Kucuksahin H; Oncu M; Guvener B
European Journal of Ophthalmology 2007; 17: 528-533
19343 Effect of nerve regeneration factor on expression of inducible-nitric oxide synthase in retina with experimental intraocular hypertension
Guan H; Huang Z; Ding F; Gu X
Chinese Ophthalmic Research 2007; 25: 325-328
19330 Alteration of retinal intrinsic survival signal and effect of α2-adrenergic receptor agonist in the retina of the chronic ocular hypertension rat
Kim HS; Chang YI; Kim JH; Park CK
Visual Neuroscience 2007; 24: 127-139
19383 Pathologically-activated therapeutics for neuroprotection: Mechanism of NMDA receptor block by memantine and S-nitrosylation
Lipton SA
Current Drug Targets 2007; 8: 621-632
19266 Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders
Lipton SA; Gu Z; Nakamura T
International review of neurobiology 2007; 82: 1-27
19267 Retinal damage caused by high intraocular pressure-induced transient ischemia is prevented by coenzyme Q10 in rat
Nucci C; Tartaglione R; Cerulli A; Mancino R; Spano A; Cavaliere F; Rombola L; Bagetta G; Corasaniti MT; Morrone LA
International review of neurobiology 2007; 82: 397-406
19436 Neurotrophic rationale in glaucoma: A TrkA agonist, but not NGF or a p75 antagonist, protects retinal ganglion cells in vivo
Shi Z; Birman E; Saragovi HU
Developmental neurobiology 2007; 67: 884-894
19557 Erythropoietin: A candidate neuroprotective agent in the treatment of glaucoma
Tsai JC; Song BJ; Wu L; Forbes M
Journal of Glaucoma 2007; 16: 567-571
